These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1698519)

  • 41. Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study.
    Van Eyken P; Sciot R; Paterson A; Callea F; Kew MC; Desmet VJ
    Hum Pathol; 1988 May; 19(5):562-8. PubMed ID: 2453442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A premature proposal for new liver cancer seromarkers.
    Wu LC; Gong WF; Zhong JH
    Tumour Biol; 2016 Apr; 37(4):4293-4. PubMed ID: 26758434
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinicopathological aspects of primary hepatocellular carcinoma occurring in patients with liver cirrhosis.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Sep; 7(5):589-605. PubMed ID: 6190271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood clot in the biliary tree due to hepatocellular carcinoma.
    Fraser GM; Zirkin H; Krugliak P
    Isr J Med Sci; 1989 Feb; 25(2):118-20. PubMed ID: 2467891
    [No Abstract]   [Full Text] [Related]  

  • 45. Cytomorphology of combined hepatocellular-cholangiocarcinoma in fine needle aspirates of the liver. A report of two cases.
    Kilpatrick SE; Geisinger KR; Loggie BW; Hopkins MB
    Acta Cytol; 1993; 37(6):943-7. PubMed ID: 7504382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of bile duct-type cytokeratin in noncancerous hepatocytes in patients with hepatitis B virus-related hepatocellular carcinoma.
    Uenishi T; Kubo S; Hirohashi K; Yamamoto T; Ogawa M; Tanaka H; Shuto T; Kinoshita H
    Hepatogastroenterology; 2003; 50(52):1101-4. PubMed ID: 12845990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abundant expression of cytokeratin 7 in fibrolamellar carcinoma of the liver.
    Van Eyken P; Sciot R; Brock P; Casteels-Van Daele M; Ramaekers FC; Desmet VJ
    Histopathology; 1990 Aug; 17(2):101-7. PubMed ID: 1699871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Expression of glypican-3, hepatocyte antigen, alpha-fetoprotein, CD34 and CD10 in hepatocellular carcinoma: a clinicopathologic analysis of 375 cases].
    Du JL; Wang YL; Shi HY; Guo AT; Wei LX
    Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):309-13. PubMed ID: 22883669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies.
    Pei RJ; Danbara N; Tsujita-Kyutoku M; Yuri T; Tsubura A
    Med Electron Microsc; 2004 Jun; 37(2):114-8. PubMed ID: 15221653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pathological study of hepatoid gastric adenocarcinomas].
    Song H; Li S; Yang Y
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):56-9. PubMed ID: 7544725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carcinoma, a fibrolamellar variant--immunohistochemical analysis of 4 cases.
    Górnicka B; Ziarkiewicz-Wróblewska B; Wróblewski T; Wilczynski GM; Koperski L; Krawczyk M; Wasiutynski A
    Hepatogastroenterology; 2005; 52(62):519-23. PubMed ID: 15816470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence.
    Sakisaka S; Watanabe M; Tateishi H; Harada M; Shakado S; Mimura Y; Gondo K; Yoshitake M; Noguchi K; Hino T
    Hepatology; 1993 Dec; 18(6):1357-62. PubMed ID: 7694895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MACC 1 as a marker for vascular invasive hepatocellular carcinoma.
    Shirahata A; Fan W; Sakuraba K; Yokomizo K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2011 Mar; 31(3):777-80. PubMed ID: 21498695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delta-like protein (DLK) is a novel immunohistochemical marker for human hepatoblastomas.
    Dezso K; Halász J; Bisgaard HC; Paku S; Turányi E; Schaff Z; Nagy P
    Virchows Arch; 2008 Apr; 452(4):443-8. PubMed ID: 18236070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High mobility group AT-hook 2 is overexpressed in hepatoblastoma.
    Lee CT; Zhang L; Mounajjed T; Wu TT
    Hum Pathol; 2013 May; 44(5):802-10. PubMed ID: 23134771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A mixed tumor of the omentum majus in an adult with discussion related to hepatoblastoma.
    Takeuchi T; Hiramatsu R; Tsuru T; Hamada T; Sato T
    Acta Pathol Jpn; 1981 Mar; 31(2):257-67. PubMed ID: 6266197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Yolk sac tumor of the liver combined with hepatocellular carcinoma.
    Morinaga S; Nishiya H; Inafuku T
    Arch Pathol Lab Med; 1996 Jul; 120(7):687-90. PubMed ID: 8757478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Preliminary study of the origin of alpha-fetoprotein (AFP) in the host hepatocytes of human liver cancer: immunohistochemical analysis of 48 cases].
    Dai YM; Ni CR
    Zhonghua Bing Li Xue Za Zhi; 1988 Dec; 17(4):247-50. PubMed ID: 2474380
    [No Abstract]   [Full Text] [Related]  

  • 59. [Bidermal hepatoblastoma in an adult (author's transl)].
    Popper H
    Zentralbl Allg Pathol; 1980; 124(5):403-9. PubMed ID: 6255703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.
    Wong IH; Lau WY; Leung T; Yeo W; Johnson PJ
    Clin Cancer Res; 1999 Dec; 5(12):4021-7. PubMed ID: 10632334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.